On this page of StockholderLetter.com we present the latest annual shareholder letter from Inotiv, Inc. — ticker symbol NOTV. Reading current and past NOTV letters to shareholders can bring important insights into the investment thesis.
10-K
Board of Directors Nigel Brown, Ph.D. Chief Executive Officer of healthcare advisory firm Terry Coelho Chief Financial Officer of a commercial stage biotechnology company Annual Meeting of Shareholders March 14, 2024 10:00 A.M. Eastern Time Courtyard Marriott Lafayette 150 Fairington Avenue Lafayette, Indiana 47905 Gregory C. Davis, Ph.D. Executive Scientific and Regulatory Consultant Auditors David Landman Senior Adviser of a global independent investment bank Ernst & Young US LLP Indianapolis, Indiana Robert Leasure, Jr. President and Chief Executive Officer R. Matthew Neff Executive Director of a real estate company John E. Sagartz, DVM, Ph.D., DACVP Chief Strategy Officer Inquiries A copy of the Company s 2023 Annual Report on Form 10-K filed with the Securities and Exchange Commission is included in this report. Additional copies are available without charge upon written request, and by visiting www.inotivco.com/investors/annual-and-quarterly-reports/. Inquiries from shareholders, security analysts, portfolio managers, registered representatives, media and other interested parties should also be directed to the following addresses. Company Contact Inotiv, Inc. Beth A. Taylor, Chief Financial Officer (765) 497-8381 btaylor@inotivco.com Investor Relations LifeSci Advisors Bob Yedid 516-428-8577 Bob@lifescieadvisors.com Transfer Agent First Class, Registered or Certified mail: Computershare Investor Services PO Box 43006 Providence, RI 02940-3006 Overnight Delivery or Courier Services: Computershare Investor Services 150 Royall St. Canton, MA 02021 Shareholder Services Toll Free: 1-877-581-5548 Shareholder Services Outside of the US and Canada:781-575- 2879 Investor CentreTM portal: www.computershare.com/investor Common Shares Inotiv, Inc. common shares are traded on the Nasdaq Capital Market under the symbol, NOTV. The following table sets forth by fiscal quarter the high and low sales prices of the common shares on the Nasdaq Capital Market. High Low Fiscal Year Ended September 30, 2023 First Quarter .. Second Quarter . Third Quarter Fourth Quarter ... $ 23.37 8.88 7.65 7.50 $ 3.65 4.14 3.86 2.90 Fiscal Year Ended September 30, 2022 First Quarter ... Second Quarter .. Third Quarter . Fourth Quarter ... $ 60.66 42.78 26.83 27.22 $28.50 18.33 9.14 9.25 The Company has not paid any cash dividends on its common shares. The Company does not intend to pay cash dividends in the foreseeable future.
 • shareholder letter icon 1/25/2024 Letter Continued (Full PDF)
 • stockholder letter icon 1/27/2023 NOTV Stockholder Letter
 • stockholder letter icon More "Biotechnology" Category Stockholder Letters
 • Benford's Law Stocks icon NOTV Benford's Law Stock Score = 99


NOTV Shareholder/Stockholder Letter Transcript:

10-K

Board of Directors
Nigel Brown, Ph.D.
Chief Executive Officer of healthcare advisory firm
Terry Coelho
Chief Financial Officer of a commercial stage biotechnology company
Annual Meeting of Shareholders
March 14, 2024
10:00 A.M. Eastern Time
Courtyard Marriott Lafayette
150 Fairington Avenue
Lafayette, Indiana 47905
Gregory C. Davis, Ph.D.
Executive Scientific and Regulatory Consultant
Auditors
David Landman
Senior Adviser of a global independent investment bank
Ernst & Young US LLP
Indianapolis, Indiana
Robert Leasure, Jr.
President and Chief Executive Officer
R. Matthew Neff
Executive Director of a real estate company
John E. Sagartz, DVM, Ph.D., DACVP
Chief Strategy Officer
Inquiries
A copy of the Company   s 2023 Annual Report on Form 10-K filed with
the Securities and Exchange Commission is included in this report.
Additional copies are available without charge upon written request, and
by visiting www.inotivco.com/investors/annual-and-quarterly-reports/.
Inquiries from shareholders, security analysts, portfolio managers,
registered representatives, media and other interested parties should also
be directed to the following addresses.
Company Contact
Inotiv, Inc.
Beth A. Taylor, Chief Financial Officer
(765) 497-8381
btaylor@inotivco.com
Investor Relations
LifeSci Advisors
Bob Yedid
516-428-8577
Bob@lifescieadvisors.com
Transfer Agent
First Class, Registered or Certified mail:
Computershare Investor Services
PO Box 43006
Providence, RI 02940-3006
Overnight Delivery or Courier Services:
Computershare Investor Services
150 Royall St.
Canton, MA 02021
Shareholder Services Toll Free: 1-877-581-5548
Shareholder Services Outside of the US and Canada:781-575- 2879
Investor CentreTM portal: www.computershare.com/investor
Common Shares
Inotiv, Inc. common shares are traded on the Nasdaq Capital Market
under the symbol, NOTV.
The following table sets forth by fiscal quarter the high and low sales
prices of the common shares on the Nasdaq Capital Market.
High
Low
Fiscal Year Ended September 30, 2023
First Quarter                            ..
Second Quarter                         .
Third Quarter                            
Fourth Quarter                         ...
$ 23.37
8.88
7.65
7.50
$ 3.65
4.14
3.86
2.90
Fiscal Year Ended September 30, 2022
First Quarter                            ...
Second Quarter                         ..
Third Quarter                            .
Fourth Quarter                         ...
$ 60.66
42.78
26.83
27.22
$28.50
18.33
9.14
9.25
The Company has not paid any cash dividends on its common shares.
The Company does not intend to pay cash dividends in the foreseeable
future.



shareholder letter icon 1/25/2024 Letter Continued (Full PDF)
 

NOTV Stockholder/Shareholder Letter (Inotiv, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.